Tefron Ltd.
TFRFF
$7.34
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 63.43M | 76.38M | 78.47M | 75.58M | 61.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 63.43M | 76.38M | 78.47M | 75.58M | 61.83M |
| Cost of Revenue | 50.36M | 57.98M | 61.37M | 57.67M | 48.12M |
| Gross Profit | 13.07M | 18.41M | 17.10M | 17.91M | 13.71M |
| SG&A Expenses | 8.58M | 9.77M | 8.55M | 8.75M | 7.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 639.00K | -- | -- | -- | 668.00K |
| Total Operating Expenses | 61.26M | 69.57M | 71.69M | 68.23M | 58.06M |
| Operating Income | 2.17M | 6.81M | 6.78M | 7.35M | 3.77M |
| Income Before Tax | 1.98M | 5.69M | 5.70M | 6.19M | 3.17M |
| Income Tax Expenses | 60.00K | 1.32M | 1.18M | 1.88M | 424.00K |
| Earnings from Continuing Operations | 1.92M | 4.37M | 4.52M | 4.31M | 2.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.92M | 4.37M | 4.52M | 4.31M | 2.75M |
| EBIT | 2.17M | 6.81M | 6.78M | 7.35M | 3.77M |
| EBITDA | 3.46M | 8.87M | 8.82M | 9.29M | 5.13M |
| EPS Basic | 0.15 | 0.35 | 0.35 | 0.35 | 0.23 |
| Normalized Basic EPS | 0.10 | 0.29 | 0.28 | 0.31 | 0.16 |
| EPS Diluted | 0.14 | 0.32 | 0.33 | 0.33 | 0.21 |
| Normalized Diluted EPS | 0.10 | 0.26 | 0.26 | 0.30 | 0.15 |
| Average Basic Shares Outstanding | 12.78M | 12.49M | 12.90M | 12.30M | 12.14M |
| Average Diluted Shares Outstanding | 12.96M | 13.66M | 13.68M | 13.05M | 13.35M |
| Dividend Per Share | -- | -- | -- | -- | 0.16 |
| Payout Ratio | 0.00% | -- | 44.18% | -- | -- |